Discovery

Clinical Pharmacology & Therapeutics (2007) 82, 310–315; doi:10.1038/sj.clpt.6100278; published online 27 June 2007

Human Embryonic Stem Cell Derivation and Nuclear Transfer: Impact on Regenerative Therapeutics and Drug Discovery

R P Cervera1 and M Stojkovic1

1Cellular Reprogramming Laboratory, Centro de Investigación Príncipe Felipe, Valencia, Spain

Correspondence: M Stojkovic, (mstojkovic@cipf.es)

Top

Abstract

This review aims to introduce current and future uses of human embryonic stem cells derived from in vitro-fertilized embryos. These and stem cells derived from parthenogenetic and nuclear transfer embryos could be used for cell therapy, as in vitro cell models for drug discovery/screening, and for studying early human development and pathogenesis of human diseases. However, development of therapeutic and screening applications and products from embryonic stem cells is hampered by several barriers. Therefore, gaps in our current understanding of the basic science of stem cells need to be filled before either application can move forward with confidence.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Stem cells The magic brew

Nature News and Views (19 Jul 2007)

Stem cells Recycling the abnormal

Nature News and Views (07 Jun 2007)

See all 3 matches for News And Views

Extra navigation

.

naturejobs

ADVERTISEMENT